REQUEST A DEMO
Total
USD $0.00
Search more companies

Exim Pharma Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Secondary Activities: All Other Food Manufacturing | Pharmaceutical and Medicine Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers | Retail Trade | Warehousing and Storage | Rental and Leasing Services
Full name: Exim Pharma Sp. z o.o. Profile Updated: April 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Exim Pharma Sp. z o.o. is an enterprise in Poland, with the main office in Warsaw. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. It was incorporated on November 27, 2015. It currently has a total number of 1 (2016) employees. The latest financial highlights indicate a net sales revenue increase of 72.03% in 2022. Its’ total assets recorded a growth of 117.75%. The net profit margin of Exim Pharma Sp. z o.o. increased by 0.47% in 2022.

Headquarters
Ul. Ogrodowa 37/50
Warsaw; Mazowieckie; Postal Code: 00-873

Contact Details: Purchase the Exim Pharma Sp. z o.o. report to view the information.

Website: http://www.eximpharma.eu

Basic Information
Total Employees:
Purchase the Exim Pharma Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Exim Pharma Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Exim Pharma Sp. z o.o. report to view the information.
Incorporation Date:
November 27, 2015
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Exim Pharma Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
72.03%
Total operating revenue
72.37%
Operating profit (EBIT)
61.4%
EBITDA
61.48%
Net Profit (Loss) for the Period
78.68%
Total assets
117.75%
Total equity
44.71%
Operating Profit Margin (ROS)
-0.96%
Net Profit Margin
0.47%
Return on Equity (ROE)
14.95%
Debt to Equity Ratio
10.31%
Quick Ratio
-0.2%
Cash Ratio
-0.34%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?